The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | J | Antiinfectives for systemic use | |
| 2 | J05 | Antivirals for systemic use | |
| 3 | J05A | Direct acting antivirals | |
| 4 | J05AJ | Integrase inhibitors | |
| 5 | J05AJ04 | Cabotegravir |
| Active Ingredient | Description | |
|---|---|---|
| Cabotegravir |
Cabotegravir inhibits HIV integrase by binding to the integrase active site and blocking the strand transfer step of retroviral deoxyribonucleic acid (DNA) integration which is essential for the HIV replication cycle. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| APRETUDE Prolonged-release suspension for injection | European Medicines Agency (EU) | MPI, EU: SmPC | |
| VOCABRIA Film-coated tablet | European Medicines Agency (EU) | MPI, EU: SmPC | |
| VOCABRIA Film-coated tablet | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| VOCABRIA Prolonged-release suspension for injection | European Medicines Agency (EU) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
